Related references
Note: Only part of the references are listed.DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)
Brad T. Sherman et al.
NUCLEIC ACIDS RESEARCH (2022)
Identifying General Tumor and Specific Lung Cancer Biomarkers by Transcriptomic Analysis
Beatriz Andrea Otalora-Otalora et al.
BIOLOGY-BASEL (2022)
Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer
Lakshya Chauhan et al.
ELIFE (2021)
RUNX2 Phosphorylation by Tyrosine Kinase ABL Promotes Breast Cancer Invasion
Fang He et al.
FRONTIERS IN ONCOLOGY (2021)
The microRNA-130a-5p/RUNX2/STK32A network modulates tumor invasive and metastatic potential in non-small cell lung cancer
Fang Ma et al.
BMC CANCER (2020)
Integrated expression analysis revealed RUNX2 upregulation in lung squamous cell carcinoma tissues
Da-Ping Yang et al.
IET SYSTEMS BIOLOGY (2020)
TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma
Daniel J. Mullen et al.
PLOS GENETICS (2020)
Clinical significance of transcription factor RUNX2 in lung adenocarcinoma and its latent transcriptional regulating mechanism
Da-Ping Yang et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2020)
Identifying cancer prognostic modules by module network analysis
Xiong-Hui Zhou et al.
BMC BIOINFORMATICS (2019)
HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
Gloria Manzotti et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers
David J. Wooten et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Joint Transcriptomic Analysis of Lung Cancer and Other Lung Diseases
Beatriz Andrea Otalora-Otalora et al.
FRONTIERS IN GENETICS (2019)
Landscape of transcriptional deregulation in lung cancer
Shu Zhang et al.
BMC GENOMICS (2018)
BRCA1 and BRCA2 tumor suppressors in neural crest cells are essential for craniofacial bone development
Kohei Kitami et al.
PLOS GENETICS (2018)
Transcription Factor and lncRNA Regulatory Networks Identify Key Elements in Lung Adenocarcinoma
Dan Li et al.
GENES (2018)
Enhancer function regulated by combinations of transcription factors and cofactors
Takeya Nakagawa et al.
GENES TO CELLS (2018)
Identification of cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers
Dimple Chudasama et al.
CARCINOGENESIS (2018)
Embryonic transcription factor SOX9 drives breast cancer endocrine resistance
Rinath Jeselsohn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity
Jiapei Lu et al.
SEMINARS IN CANCER BIOLOGY (2017)
Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine
Hala Fawzy Mohamed Kamel et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2017)
The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Zheng Fu et al.
CANCERS (2017)
MicroRNA-196b Inhibits Cell Growth and Metastasis of Lung Cancer Cells by Targeting Runx2 (Publication with Expression of Concern. See vol. 55, pg. 238, 2021)
Xiaoxue Bai et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Combinatorial function of transcription factors and cofactors
Franziska Reiter et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)
Transcriptome Analysis of Recurrently Deregulated Genes across Multiple Cancers Identifies New Pan-Cancer Biomarkers
Bogumil Kaczkowski et al.
CANCER RESEARCH (2016)
WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2
Q-W Zheng et al.
CANCER GENE THERAPY (2016)
Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells
Rubiceli Medina-Aguilar et al.
ONCOLOGY REPORTS (2016)
Reconstruction of gene regulatory networks reveals chromatin remodelers and key transcription factors in tumorigenesis
Valeriya Malysheva et al.
GENOME MEDICINE (2016)
Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer
D. Jurkovicova et al.
NEOPLASMA (2016)
COREGNET: reconstruction and integrated analysis of co-regulatory networks
Remy Nicolle et al.
BIOINFORMATICS (2015)
RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression
Karine A. Cohen-Solal et al.
MOLECULAR CANCER (2015)
RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells
Jessica L. Brusgard et al.
ONCOTARGET (2015)
Non-small-cell lung cancer
Cesare Gridelli et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Regulation of Epithelial-Mesenchymal Transition through SUMOylation of Transcription Factors
Maria V. Bogachek et al.
CANCER RESEARCH (2015)
Construction and comparison of gene co-expression networks shows complex plant immune responses
Luis Guillermo Leal et al.
PEERJ (2014)
Connection between tumor suppressor BRCA1 and PTEN in damaged DNA repair
Akari Minami et al.
FRONTIERS IN ONCOLOGY (2014)
Interfacing cellular networks of S. cerevisiae and E. coli: Connecting dynamic and genetic information
Ricardo de Matos Simoes et al.
BMC GENOMICS (2013)
Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer
Kening Li et al.
BMC SYSTEMS BIOLOGY (2013)
Biostatistical approaches for the reconstruction of gene co-expression networks based on transcriptomic data
Liliana Lopez-Kleine et al.
BRIEFINGS IN FUNCTIONAL GENOMICS (2013)
Hypoxia inhibits the differentiation of mesenchymal stem cells into osteoblasts by activation of Notch signaling
Ningru Xu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1
Liduan Zheng et al.
PLOS ONE (2013)
Transcriptional Regulatory Cascades in Runx2-Dependent Bone Development
Tong Ming Liu et al.
TISSUE ENGINEERING PART B-REVIEWS (2013)
Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up study
Hong Li et al.
TUMOR BIOLOGY (2013)
Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage
T. Ozaki et al.
CELL DEATH & DISEASE (2013)
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms
Qian Qin et al.
CELL RESEARCH (2012)
Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells
Manish Tandon et al.
MOLECULAR CANCER (2012)
Transcriptional regulatory networks in human lung adenocarcinoma
Xiangrui Meng et al.
MOLECULAR MEDICINE REPORTS (2012)
A Transcriptional Network Signature Characterizes Lung Cancer Subtypes
Hsun-Hsien Chang et al.
CANCER (2011)
Lung Cancer: Epidemiology, Etiology, and Prevention
Charles S. Dela Cruz et al.
CLINICS IN CHEST MEDICINE (2011)
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension
Md. Talat Nasim et al.
HUMAN MUTATION (2011)
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Renato V. Iozzo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Identification of a Novel Biomarker, SEMA5A, for Non-Small Cell Lung Carcinoma in Nonsmoking Women
Tzu-Pin Lu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Identification of DOK genes as lung tumor suppressors
Alice H. Berger et al.
NATURE GENETICS (2010)
Cancer Genomics Identifies Regulatory Gene Networks Associated with the Transition from Dysplasia to Advanced Lung Adenocarcinomas Induced by c-Raf-1
Astrid Rohrbeck et al.
PLOS ONE (2009)
Systematic construction of gene coexpression networks with applications to human T helper cell differentiation process
Laura L. Elo et al.
BIOINFORMATICS (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
The suppressive effect of myeloid elf-1-like factor (MEF) in osteogenic differentiation
Younjeong Kim et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Statistical analysis of gene regulatory networks reconstructed from gene expression data of lung cancer
Lanfang Sun et al.
PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS (2006)
4-year mortality in patients with non-small-cell lung cancer: Development and validation of a prognostic index
Francois Blanchon et al.
LANCET ONCOLOGY (2006)
Cyclin D1-Cdk4 induce Runx2 ubiquitination and degradation
Run Shen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
CBFβ is a facultative Runx partner in the sea urchin embryo
AJ Robertson et al.
BMC BIOLOGY (2006)
TAZ, a transcriptional modulator of mesenchymal stem cell differentiation
JH Hong et al.
SCIENCE (2005)
Runx1/UAML1 in normal and abnormal hematopoiesis
T Yamagata et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription
SK Zaidi et al.
EMBO JOURNAL (2004)
The Runx genes:: lineage-specific oncogenes and tumor suppressors
ER Cameron et al.
ONCOGENE (2004)
Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression
GS Stein et al.
ONCOGENE (2004)
Histone deacetylase 3 interacts with Runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation
TM Schroeder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains
KS Harrington et al.
JOURNAL OF CELL SCIENCE (2002)
Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
RC Trembath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Runx2:: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging
K Blyth et al.
ONCOGENE (2001)
Share Paper
